✦ LIBER ✦

CMF beneficial in HER2-positive and -negative tumours

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poor survival outcomes in HER2-positive

✍ Tovey, S M; Brown, S; Doughty, J C; Mallon, E A; Cooke, T G; Grant, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Poor survival outcomes in HER2 positive

✍ Sian Tovey; J. Edwards; S. Brown; E. Mallon; T. Cooke 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Poor survival outcomes in HER2 positive

✍ S.M. Tovey; J. Edwards; S.B. Brown; E. Mallon; T.G. Cooke 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Poor survival outcomes in HER2-positive

✍ Chavez-Mac Gregor, M.; Gonzalez-Angulo, A.M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 120 KB

FDG PET/CT during neoadjuvant chemothera

✍ Koolen, Bas B.; Pengel, Kenneth E.; Wesseling, Jelle; Vogel, Wouter V.; Vrancken 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 535 KB

O-18 PARP1 expression in hormone estroge

✍ Ahmed A. Benhasouna; Andrew R. Green; Des G. Powe; Muhammad A. Aleskandarany; Em 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 32 KB